585414 tn?1288944902
New Medications in Study for Melanoma
"....The Roche drug and ipilimumab, an experimental drug for advanced melanoma being developed by U.S. group Bristol-Myers Squibb (BMY.N), promise new hope for patients who have so far had few options.
Roche had previously said it was aiming to file for approval of the medicine, which it has been developing with privately held Plexxikon, for approval in the second half and was hoping to launch the drug late next year or in early 2013.
The submissions are based on two studies.
  The BRIM3 trial showed the drug helps patients live longer and also extends the period in which their disease does not get worse compared with those taking dacarbazine, the current standard of care, while the BRIM2 trial showed vemurafenib shrank tumours in 52 percent of trial participants.
Full data from the BRIM3 study and updated data from the BRIM2 trial will be presented at the annual meeting of the American Society of Clinical Oncology next month. ($1 = 0.9607 Swiss francs) (Editing by Dan Lalor and Greg Mahlich).."
Discussion is closed
0 Answers
Page 1 of 1
You must join this user group in order to participate in this discussion.
Recent Activity
675718 tn?1449992146
drifter0213 commented on gma
Sep 20
406584 tn?1399591666
10356 commented on gma
Sep 19
Avatar universal
Casbo143 commented on gma
Sep 15